225 related articles for article (PubMed ID: 19515066)
21. Pitavastatin inhibits cardiac hypertrophy in a rat model of progressive renal injury.
Takahashi H; Takeishi Y; Arimoto T; Shishido T; Konta T; Koyama Y; Niizeki T; Kubota I
J Cardiovasc Pharmacol; 2005 Oct; 46(4):487-93. PubMed ID: 16160602
[TBL] [Abstract][Full Text] [Related]
22. FAK-related nonkinase attenuates hypertrophy induced by angiotensin-II in cultured neonatal rat cardiac myocytes.
Qin J; Liu ZX
Acta Pharmacol Sin; 2006 Sep; 27(9):1159-64. PubMed ID: 16923336
[TBL] [Abstract][Full Text] [Related]
23. Scaffolding protein Homer 1c mediates hypertrophic responses downstream of Gq in cardiomyocytes.
Grubb DR; Luo J; Yu YL; Woodcock EA
FASEB J; 2012 Feb; 26(2):596-603. PubMed ID: 22012123
[TBL] [Abstract][Full Text] [Related]
24. [Molecular mechanism of nitric oxide in preventing cardiomyocytes from hypertrophic response induced by angiotensin II].
Liu PQ; Lu W; Pan JY
Sheng Li Xue Bao; 2002 Jun; 54(3):213-8. PubMed ID: 12075467
[TBL] [Abstract][Full Text] [Related]
25. Statins as antioxidant therapy for preventing cardiac myocyte hypertrophy.
Takemoto M; Node K; Nakagami H; Liao Y; Grimm M; Takemoto Y; Kitakaze M; Liao JK
J Clin Invest; 2001 Nov; 108(10):1429-37. PubMed ID: 11714734
[TBL] [Abstract][Full Text] [Related]
26. [MKP-1 regulates the cardiomyocyte hypertrophic responses induced by angiotensin II].
Liu PQ; Lu W; Wang TH; Pan JY
Sheng Li Xue Bao; 2000 Oct; 52(5):365-70. PubMed ID: 11941388
[TBL] [Abstract][Full Text] [Related]
27. SIRT1 functions as an important regulator of estrogen-mediated cardiomyocyte protection in angiotensin II-induced heart hypertrophy.
Shen T; Ding L; Ruan Y; Qin W; Lin Y; Xi C; Lu Y; Dou L; Zhu Y; Cao Y; Man Y; Bian Y; Wang S; Xiao C; Li J
Oxid Med Cell Longev; 2014; 2014():713894. PubMed ID: 25614777
[TBL] [Abstract][Full Text] [Related]
28. Effect of atorvastatin on cardiomyocyte hypertrophy through suppressing MURC induced by volume overload and cyclic stretch.
Cheng WP; Lo HM; Wang BW; Chua SK; Shyu KG
J Cell Mol Med; 2019 Feb; 23(2):1406-1414. PubMed ID: 30511410
[TBL] [Abstract][Full Text] [Related]
29. Isorhapontigenin, a new resveratrol analog, attenuates cardiac hypertrophy via blocking signaling transduction pathways.
Li HL; Wang AB; Huang Y; Liu DP; Wei C; Williams GM; Zhang CN; Liu G; Liu YQ; Hao DL; Hui RT; Lin M; Liang CC
Free Radic Biol Med; 2005 Jan; 38(2):243-57. PubMed ID: 15607907
[TBL] [Abstract][Full Text] [Related]
30. Knockdown of farnesylpyrophosphate synthase prevents angiotensin II-mediated cardiac hypertrophy.
Ye Y; Mou Y; Bai B; Li L; Chen GP; Hu SJ
Int J Biochem Cell Biol; 2010 Dec; 42(12):2056-64. PubMed ID: 20884373
[TBL] [Abstract][Full Text] [Related]
31. Effect of endostatin overexpression on angiotensin II-induced cardiac hypertrophy in rats.
Dai YJ; Gong JX; Bian R
Chin Med J (Engl); 2019 Nov; 132(22):2716-2723. PubMed ID: 31725448
[TBL] [Abstract][Full Text] [Related]
32. Propofol depresses angiotensin II-induced cardiomyocyte hypertrophy in vitro.
Zou XJ; Yang L; Yao SL
Exp Biol Med (Maywood); 2008 Feb; 233(2):200-8. PubMed ID: 18222975
[TBL] [Abstract][Full Text] [Related]
33. Adapter molecule DOC-2 is differentially expressed in pressure and volume overload hypertrophy and inhibits collagen synthesis in cardiac fibroblasts.
Kumbar DH; VanBergen A; Ocampo C; Muangmingsuk S; Griffin AJ; Gupta M
J Appl Physiol (1985); 2007 May; 102(5):2024-32. PubMed ID: 17255372
[TBL] [Abstract][Full Text] [Related]
34. Klotho inhibits angiotensin II-induced cardiomyocyte hypertrophy through suppression of the AT1R/beta catenin pathway.
Yu L; Meng W; Ding J; Cheng M
Biochem Biophys Res Commun; 2016 Apr; 473(2):455-61. PubMed ID: 26970306
[TBL] [Abstract][Full Text] [Related]
35. Inhibitory effect of antisense oligodeoxynucleotide to p44/p42 MAPK on angiotensin II-induced hypertrophic response in cultured neonatal rat cardiac myocyte.
Zhang SQ; Ding B; Guo ZG; Li YX
Acta Pharmacol Sin; 2004 Jan; 25(1):41-6. PubMed ID: 14704121
[TBL] [Abstract][Full Text] [Related]
36. Angiotensin II and the ERK pathway mediate the induction of myocardin by hypoxia in cultured rat neonatal cardiomyocytes.
Chiu CZ; Wang BW; Chung TH; Shyu KG
Clin Sci (Lond); 2010 Jun; 119(7):273-82. PubMed ID: 20446923
[TBL] [Abstract][Full Text] [Related]
37. PPARdelta activation inhibits angiotensin II induced cardiomyocyte hypertrophy by suppressing intracellular Ca2+ signaling pathway.
Lee KS; Park JH; Lee S; Lim HJ; Park HY
J Cell Biochem; 2009 Apr; 106(5):823-34. PubMed ID: 19224536
[TBL] [Abstract][Full Text] [Related]
38. Simvastatin prevents cardiac hypertrophy in vitro and in vivo via JAK/STAT pathway.
Liu J; Shen Q; Wu Y
Life Sci; 2008 May; 82(19-20):991-6. PubMed ID: 18400235
[TBL] [Abstract][Full Text] [Related]
39. FKBP12.6 protects heart from AngII-induced hypertrophy through inhibiting Ca
Xiao YF; Zeng ZX; Guan XH; Wang LF; Wang CJ; Shi H; Shou W; Deng KY; Xin HB
J Cell Mol Med; 2018 Jul; 22(7):3638-3651. PubMed ID: 29682889
[TBL] [Abstract][Full Text] [Related]
40. Involvement of calcium-sensing receptor in cardiac hypertrophy-induced by angiotensinII through calcineurin pathway in cultured neonatal rat cardiomyocytes.
Wang LN; Wang C; Lin Y; Xi YH; Zhang WH; Zhao YJ; Li HZ; Tian Y; Lv YJ; Yang BF; Xu CQ
Biochem Biophys Res Commun; 2008 May; 369(2):584-9. PubMed ID: 18295598
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
